Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Maplirpacept

🥰Excellent
Catalog No. T9901A-1530Cas No. 2631667-06-4
Alias TTI-622, PF-07901801

Maplirpacept (TTI-622; PF-07901801) is a fusion protein composed of the CD47 binding domain of human SIRPα linked to the Fc region of human IgG4. It enhances phagocytosis by inhibiting CD47.

Maplirpacept

Maplirpacept

🥰Excellent
Catalog No. T9901A-1530Alias TTI-622, PF-07901801Cas No. 2631667-06-4
Maplirpacept (TTI-622; PF-07901801) is a fusion protein composed of the CD47 binding domain of human SIRPα linked to the Fc region of human IgG4. It enhances phagocytosis by inhibiting CD47.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Maplirpacept (TTI-622; PF-07901801) is a fusion protein composed of the CD47 binding domain of human SIRPα linked to the Fc region of human IgG4. It enhances phagocytosis by inhibiting CD47.
SynonymsTTI-622, PF-07901801
Application
FACS
Functional assay
Antibody Type
Monoclonal
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Chemical Properties
Cas No.2631667-06-4
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Maplirpacept | purchase Maplirpacept | Maplirpacept cost | order Maplirpacept